Trial Profile

An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 24 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paltusotine (Primary)
Indications Acromegaly
Focus Adverse reactions
Acronyms ACROBAT ADVANCE
Sponsors Crinetics Pharmaceuticals

Most Recent Events

24 Jun 2025 Last checked against ClinicalTrials.gov record.
15 May 2025 According to a Crinetics Pharmaceuticals media release, company will present post hoc data from PATHFNDR-1, PATHFNDR-2, and ACROBAT Advance studies at the American Association of Clinical Endocrinology (AACE) Annual Meeting 2025, taking place May 15-17 in Orlando, FL.
03 Jun 2024 Results published in a Crinetics Pharmaceuticals media release

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com